mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |